Kodiak Sciences (KOD) Change in Accured Expenses (2017 - 2026)
Kodiak Sciences' (KOD) quarterly Change in Accured Expenses came in at $4.6 million in Q1 2026, up 93.55% YoY from $2.4 million in Q1 2025, and up 228000.0% on a QoQ basis from -$2000.0 in Q4 2025.
Analysis
Kodiak Sciences (KOD) Change in Accured Expenses (2017 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 10 years of Change in Accured Expenses data on file, last reported at $4.6 million in Q1 2026.
- Quarterly Change in Accured Expenses rose 93.55% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.5 million (up 1913.33% YoY) and the FY2025 annual result came in at $9.3 million, up 225.8% from the prior year.
- Change in Accured Expenses rose to $4.6 million in Q1 2026, from -$2000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $13.7 million in Q1 2022 to a low of -$12.2 million in Q2 2022.
- A 5-year average of -$511352.9 and a median of $408000.0 in 2024 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses plunged 403.28% — and 2025, when it soared 398.59%.
- Tracing KOD's Change in Accured Expenses over 5 years: stood at -$7.6 million in 2022, then jumped by 39.27% to -$4.6 million in 2023, then jumped by 108.79% to $408000.0 in 2024, then tumbled by 100.49% to -$2000.0 in 2025, then jumped by 228000.0% to $4.6 million in 2026.
- The last three Change in Accured Expenses figures came in at $4.6 million (Q1 2026), -$2000.0 (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 11.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 55.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 212.44 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 61.62 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Kodiak Sciences | 2.21 Bn | 2.21 Bn | - | 3.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.51 Mn |
| Mar 31, 2026 | 4.56 Mn |
| Dec 31, 2025 | -2,000.00 |
| Sep 30, 2025 | 5.64 Mn |
| Jun 30, 2025 | 1.28 Mn |
| Mar 31, 2025 | 2.36 Mn |
| Dec 31, 2024 | 408,000.00 |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | -3.32 Mn |
| Mar 31, 2024 | -5.59 Mn |
| Dec 31, 2023 | -4.64 Mn |
| Sep 30, 2023 | -3.99 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | -5.37 Mn |
| Dec 31, 2022 | -7.65 Mn |
| Sep 30, 2022 | 3.86 Mn |
| Jun 30, 2022 | -12.15 Mn |
| Mar 31, 2022 | 13.70 Mn |
| Dec 31, 2021 | 2.96 Mn |
| Sep 30, 2021 | -4.91 Mn |